Variant position: 320 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 395 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human ESLDVYELDAKQGRWYVVQT NYDRWKHPFFLDDRRTPAKMC
Chimpanzee ESLDVYELDAKQGRWYVVQT NYDRWKHPFFLDDRRTPAKMC
Mouse ESLDVYELDPKHGRWYVVQT NYDRWKNTLFIDDRRTPAKKC
Rat ESLDVYELDPKHGRWYVVQT NYDRWKNTLFLDDRRTPAKKC
Bovine QSLDIYELDPKHGRWYVVQT NYDRWKNPFFLDDRRTPAKMC
Caenorhabditis elegans KTALLTEMATSPHGWYLLET NYDQGTEDLYLDDRDTPGFRC
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
143 – 395 Acid ceramidase subunit beta
320 – 320 Important for catalytic activity
333 – 333 Important for catalytic activity
31 – 340 Interchain (between alpha and beta subunits)
320 – 320 N -> A. Strongly decreased autocatalytic processing. Mildly decreased ceramidase activity.
333 – 333 R -> Q. Mildly decreased autocatalytic processing. Loss of ceramidase activity.
Human acid ceramidase gene: novel mutations in Farber disease.
Zhang Z.; Mandal A.K.; Mital A.; Popescu N.; Zimonjic D.; Moser A.; Moser H.; Mukherjee A.B.;
Mol. Genet. Metab. 70:301-309(2000)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS FRBRL HIS-22; ASP-23; VAL-138; LYS-222 AND ASP-320; VARIANTS MET-72; VAL-93 AND ALA-246;
Molecular analysis of acid ceramidase deficiency in patients with Farber disease.
Bar J.; Linke T.; Ferlinz K.; Neumann U.; Schuchman E.H.; Sandhoff K.;
Hum. Mutat. 17:199-209(2001)
Cited for: VARIANTS FRBRL CYS-36 AND ASP-320;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.